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Thymic stromal lymphopoietin (TSLP) is a functionally pleotropic cytokine important in
immune regulation, and TSLP dysregulation is associated with numerous diseases. TSLP
is produced by many cell types, but has predominantly been characterized as a secreted
factor from epithelial cells which activates dendritic cells (DC) that subsequently prime
T helper (TH ) 2 immunity. However, DC themselves make significant amounts of TSLP
in response to microbial products, but the functional role of DC-derived TSLP remains
unclear. We show that TSLPR signaling negatively regulates IL-1β production during
dectin-1 stimulation of human DC. This regulatory mechanism functions by dampening
Syk phosphorylation and is mediated via NADPH oxidase-derived ROS, HIF-1α and
pro-IL-1β expression. Considering the profound effect TSLPR signaling has on the
metabolic status and the secretome of dectin-1 stimulated DC, these data suggest that
autocrine TSLPR signaling could have a fundamental role in modulating immunological
effector responses at sites removed from epithelial cell production of TSLP.
Keywords: TSLP, dectin-1, IL-1β, hypoxia, ROS, HIF-1α, Syk

INTRODUCTION
Thymic Stromal Lymphopoietin (TSLP) is a four-helix bundle cytokine belonging to the IL-2
family that was initially described as a lymphocyte growth factor (1). Since this initial report, it
has been shown to be produced by a plethora of cell types (2–8). Functionally TSLP is pleotropic;
TSLP is described to have an important role in maintaining tolerance within the gut (9, 10) yet
it is implicated in asthma (11) and in the skin in both the development of itch (12) and atopic
inflammation (12–14). TSLP binds to its unique receptor, called the TSLP receptor (TSLPR)
composed of a unique TSLPR chain and the IL-7 receptor alpha (15) which initiates JAK-STAT
mediated activation of downstream target genes (16–18).
Dendritic cells (DC) are immunologically important TSLP responsive cells (19). DC activated
with TSLP can induce naïve CD4+ T cell proliferation (20) and T helper (TH ) 2-cell differentiation
(21) which requires the up-regulation of OX40L on the DC (22). DC can also produce TSLP in
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dectin-1 stimulation (Figure 1H). Augmented IL-1β, IL-6, and
IL-23 were all dependent on signaling through dectin-1 via Syk
(Supplemental Figures 1A–F). To ensure that this effect was not
an artifact caused by antibody binding and subsequent mDC
activation, we generated bone marrow-derived dendritic cells
(BMDC) from wildtype TSLPR+/+ and knockout TSLPR−/−
BALB/c mice. In agreement with the results using TSLPR
blocking antibodies, TSLPR−/− BMDC stimulated with either
C. albicans or β-glucans produced more IL-1β, IL-6, and IL-23
compared to TSLPR+/+ BMDC (Figures 1D–F). Furthermore,
inhibiting TSLPR signaling on human blood-derived CD1c+ DC
also increased IL-1β secretion confirming that these findings were
not an artifact of in vitro differentiation of monocytes (Figure 1I).

response to pattern recognition receptor (PRR) engagement (3,
4, 8, 23). Therefore, DC are the only cell population known to
both produce and respond to TSLP by altering their effector
responses. However, the functional role of DC-derived TSLP
remains unclear; this work addresses this issue.
Amongst PRRs, dectin-1 stimulation induces TSLP
production by DC (8, 23). Dectin-1 recognizes exposed β-1,3
glucan residues on the cell surface of fungi and studies utilizing
dectin-1 gene knockout (−/− ) mice emphasize the importance
of this PRR to anti-fungal immunity (24). Activation of dectin-1
signaling induces immunological effector responses including
phagocytosis (25), oxidative burst (26, 27) and the secretion
of inflammatory cytokines including IL-1β, IL-6, and IL-23
(27–32). IL-1β production plays a critical role in the generation
of protective anti-fungal immunity (33, 34). However, IL-1β
dysregulation is associated with numerous diseases including
inflammatory bowel disease (IBD) and auto-inflammatory
conditions such as the cryopyrin associated periodic syndromes
(CAPS) (35, 36). Therefore, IL-1β production is tightly regulated
in DC, requiring two independent signals for its production.
An initial priming signal (signal 1) is generated from ligation
of PRRs, activating the inflammatory transcription factor
NF-κB required for the up-regulated transcription of proIL-1β (36). A second activatory signal (signal 2) then causes
inflammasome-mediated cleavage of pro-IL-1β into its active
form (26, 27, 30, 32, 36–39). Recent work has augmented the
understanding of IL-1β regulation, describing how changes
to cellular metabolism after PRR stimulation regulate IL-1β
expression (40, 41).
We report here that autocrine TSLPR signaling in human DC
negatively regulates IL-1β production in response to dectin-1
stimulation. It likely does this through limiting a metabolic switch
to glycolysis in DC which is required for IL-1β expression.

TSLPR Signaling Negatively Regulates IL-6
and IL-23 Secretion by Controlling IL-1β
The importance of IL-1β for generating effective antifungal immunity is well-established (31). Therefore, we
wanted to determine whether the increase in IL-6 and IL23 secretion from mDC was a direct effect of inhibiting
TSLPR signaling on production of these cytokines or due
to the effects of increased IL-1β. We have showed that IL1β mRNA expression precedes that of IL-6 and IL-23p40
(Supplemental Figures 2A–D) and inhibition of IL-1 receptor
signaling with IL-1 receptor antagonist (IL-1RA) significantly
inhibits IL-6 and IL-23 secretion from SC glucan-stimulated
mDC (Supplemental Figures 2E,F). However, to directly
address this, we stimulated mDC with C. albicans or β-glucans
and neutralized TSLPR signaling in the presence or absence
of IL-1RA, or caspase-1 and caspase-8 inhibitors to prevent
inflammasome-mediated processing of IL-1β which our group
has previously demonstrated (8). This showed that the increased
IL-6 and IL-23 observed when TSLPR was blocked, was
reduced in the presence of IL-1RA or caspase-1 and caspase-8
inhibitors (Figures 2A–F). Therefore, autocrine TSLPR signaling
indirectly regulated IL-6 and IL-23 secretion by its effect on
IL-1β production.

RESULTS
Inhibition of TSLPR Signaling in mDC
Modulates IL-1β Production
DC secretion of TSLP can be readily induced following
dectin-1 stimulation (4, 8, 23). We investigated the functional
relevance of DC-derived TSLP by neutralizing TSLP signaling
in human monocyte-derived dendritic cells (mDC) which
had been stimulated with heat-killed C. albicans or β-glucan
purified from either S. cerevisiae (SC glucan) or C. albicans
(CA glucan). We blocked TSLP activity or TSLPR signaling
using neutralizing antibodies, and evaluated IL-1β, IL-6, IL23, TSLP, and CCL22 secretion. Inhibition of either TSLP
or TSLPR on mDC augmented the production of IL-1β, IL6, IL-23 (Figures 1A–C), and TSLPR inhibition augmented
TSLP itself (Figure 1G) from mDC in response to dectin1 stimulation. These effects were not observed using control
antibodies. CCL22 is a known TSLP-responsive chemokine
in epithelial cells (21), and as expected inhibition of TSLPR
signaling also reduced DC CCL22 production in response to

Dectin-1-Induced TSLP Negatively
Regulates Pro-IL-1β and HIF-1α
Recent work has described how LPS-treated macrophages and
β-glucan-stimulated monocytes undergo a metabolic switch
toward glycolysis and away from oxidative phosphorylation
(40). This is a process which has many parallels with the
Warburg effect observed in tumors. We observed that mDC
culture media was more acidic when TSLPR signaling was
neutralized during dectin-1 stimulation. Therefore, we measured
lactate production to determine whether increased lactic
acid production accounted for the pH change. Significantly
higher concentrations of lactate were indeed detected in
cell culture supernatants from mDC when TSLPR signaling
was neutralized (Figure 3A) and from TSLPR−/− BMDC
(Supplemental Figure 3A), suggesting that autocrine mDCderived TSLP negatively regulates this metabolic shift to lactate
production. Tannahill et al reported that this cellular metabolic
switch was crucial for pro-IL-1β expression via the induction

Abbreviations: TSLP, Thymic stromal lymphopoietin; mDC, monocyte-derived
DC; BMDC, bone marrow-derived dendritic cell.
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FIGURE 1 | Inhibition of TSLPR signaling in mDC modulates IL-1β production. (A–C,G,H) Human mDC stimulated with SC glucan, CA glucan or heat killed C.
albicans hyphae with anti-TSLP, anti-TSLPR or IgG isotype control antibodies for 24 h (n = 14 independent donors, presented as pooled data for SC glucan
stimulated mDC), (n = 6 independent donors, presented as pooled data for CA glucan stimulated mDC) and (n = 10 independent donors, presented as pooled data
for heat killed C. albicans hyphae stimulated mDC). (D–F) Wildtype TSLPR+/+ or TSLPR−/− BMDC derived from BALB/c mice were stimulated with, SC glucan, CA
glucan or C. albicans hyphae for 24 h (n = 4 independent animals from a representative experiment, presented as pooled data. Experiment was repeated four times).
(I) Human ex vivo CD1c+ DC stimulated with SC glucan with anti-TSLPR or IgG isotype control antibodies for 24 h (n = 3 independent donors, presented as pooled
data). IL-1β, IL-6, IL-23, TSLP and CCL22 was measured in 24-h cell culture supernatants by ELISA. Cumulative data displayed as mean ±SEM. Statistical analysis
calculated using one-way ANOVA with Bonferroni post-tests (***p = 0.001, **p = 0.01, *p = 0.05).

Frontiers in Immunology | www.frontiersin.org

3

May 2019 | Volume 10 | Article 921

Elder et al.

TSLP Negatively Regulates Dectin-1 Signaling

FIGURE 2 | mDC-derived TSLP indirectly regulates IL-6 and IL-23 secretion by controlling IL-1β production. Human mDC stimulated with, (A,B) SC glucan, (C,D) CA
glucan or (E,F) heat killed C. albicans hyphae with anti-TSLPR or IgG isotype control antibodies in the presence or absence of IL-RA, caspase-1 inhibitor or caspase-8
inhibitor for 24 h (n = 3 independent donors, presented as pooled data). IL-6 and IL-23 was measured in 24-h cell culture supernatants by ELISA. Cumulative data
displayed as mean ±SEM. Statistical analysis calculated using one-way ANOVA with Bonferroni post-tests (ns = not significant, ***p = 0.001, **p = 0.01, *p = 0.05).

(Supplemental Figure 3B). The enhancement in HIF-1α
expression could not be explained by changes in gene expression
since HIF-1α mRNA expression was not significantly modulated
by inhibition of TSLPR signaling. In contrast pro-IL-1β mRNA
expression was augmented in mDC when TSLPR activity was

of the transcription factor, hypoxia-inducible factor 1-alpha
(HIF-1α), and in agreement with this report TSLP or TSLPR
neutralization in mDC during dectin-1 signaling augmented
both HIF-1α and pro-IL-1β protein expression (Figures 3B–E).
An identical augmentation was observed in TSLPR−/− BMDC
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with the Syk inhibitor R406 reduced SC glucan-induced HIF1α and pro-IL-1β expression (Supplemental Figure 6A). We
hypothesized that TSLPR signaling may directly modulate Syk
activation and therefore examined the phosphorylation status
of critical Tyr residues in Syk which are associated with its
activation and interaction with downstream signaling pathways.
As expected, SC glucan-induced Syk phosphorylation (Tyr
525/526) was dectin-1 dependent (Supplemental Figure 6B).
Neutralization of autrocrine TSLPR signaling resulted in
enhanced Syk phosphorylation at this residue (Figures 6A–D).
Furthermore, analysis of the phosphorylation state of other
Tyr residues associated with Syk activation was also enhanced
(Figures 6A,C). These data suggest that autocrine mDC-derived
TSLP limits Syk-mediated activation. This in turn may negatively
regulate the metabolic shift to glycolysis, the production of HIF1α and hence expression of pro-IL-1β.

neutralized (Supplemental Figures 4A,B). These effects were
specific and not as a result of a general increase in expression
of effector molecules downstream of dectin-1 signaling;
for instance p38 mitogen-activated protein kinase (MAPK)
activation (Thr 180/Tyr 182) was not modulated by TSLP or
TSLPR neutralization (Figures 3B,F). It has previously been
shown that chemicals which induce AMP-activated protein
kinase (AMPK) activation can oppose the metabolic switch in
DCs and macrophages which is induced by PRR stimulation
(41). Accordingly, neutralization of TSLPR signaling reduced
phosphorylation of Thr 172 on the catalytic subunit of AMPK, a
key modification required for AMPK activation (Figures 3B,G).
To determine whether the modulation of HIF-1α expression and
AMPK phosphorylation occurred as a result of the increased
IL-1β expression, IL-1β activity was neutralized in combination
with inhibition of TSLPR signaling. This showed that the
modulation of AMPK activation by inhibition of TSLPR activity
was dependent on IL-1β signaling, but this did not apply to
HIF-1α expression (Figures 4A–C).

DISCUSSION
We have previously demonstrated that human mDC and murine
BMDC generate TSLP in response to C. albicans or β-glucans
(8, 23). In this study, we showed that this TSLP acts in an
mDC autocrine fashion to regulate IL-1β, and hence IL-6 and
IL-23 production. We propose that this increase in inflammatory
cytokine expression which is seen when DC responses to TSLP
are blocked is a result of enhanced HIF-1α expression and a
more marked glycolytic shift in the metabolism of the DC.
Furthermore, we showed that TSLPR signaling dampens Syk
phosphorylation likely acting to decrease HIF-1α and pro-IL1β production.
TSLPR signaling negatively regulates IL-1β production, which
in turn modulates the expression of IL-6 and IL-23. It is wellestablished that IL-1β production plays a critical role in the
generation of protective anti-fungal immunity (31); however,
IL-1β dysregulation is associated with IBD and CAPS such as
Muckle-Wells syndrome (35, 36). Given the importance of IL1β regulation, we speculate that DC-derived TSLP acts as an
important molecular checkpoint to limit IL-1β-mediated effector
responses. Furthermore, the differentiation of naïve CD4+ T cells
to TH 1- and TH 17-cells is important for protective anti-fungal
immunity and the inflammatory cytokines IL-1β, IL-6, and IL-23
are important in generating these T cell phenotypes (28, 31, 42–
44). TSLPR−/− mice have been shown to produce more IFN-γ
in an experimental modal of Trypanosoma congolense infection
(45), more IFN-γ and IL-17 in an inducible modal of colitis
(46) compared to TSLPR+/+ mice and IL-1β is crucial for the
generation of inflammatory IFN-γ/IL-17 double producing T
cells during C. albicans infection (31, 42). Given that autocrine
TSLPR signaling negatively regulated IL-1β production during C.
albicans and β-glucan stimulation: TSLPR signaling might also
function to regulate TH 1- and TH 17-cell differentiation.
Recent work has established that myeloid-derived cells
stimulated with activators of PRRs switch from oxidative
phosphorylation to aerobic glycolysis (40). Similarly, we observed
that C. albicans and β-glucan stimulated mDC also induced HIF1α and increased the production of lactate. Furthermore, both

Dectin-1-Induced TSLP Limits IL-1β,
HIF-1α Expression, Syk Phosphorylation
and the Activation of NADPH
Oxidase-Derived ROS
It has previously been shown that reactive oxygen species
(ROS) are induced in macrophages during dectin-1 signaling
and are important for IL-1β production (26, 27). Chronic
granulomatous disease (CGD) patients possess mutations in
genes encoding proteins that form the nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH) complex; thus these
patients are unable to generate NADPH oxidase-derived ROS
(Supplemental Figure 5) and TSLP from mDC in response
to dectin-1 agonists (23). mDC from CGD donors did not
show induction of HIF-1α and pro-IL-1β in response to
dectin-1 signaling, highlighting the critical role of ROS in the
expression of HIF-1α and pro-IL1β by DCs (Figures 5A–D). In
contrast, induction of AMPK phosphorylation was unaffected
by the absence of a functional NADPH oxidase (Figures 5A,E),
indicating that AMPK activation has distinct signaling from
that required for HIF-1α expression. Given the important role
of ROS in HIF-1α protein expression, we investigated whether
inhibition of TSLPR signaling in CGD patients modulated IL1β production. TSLPR neutralization during dectin-1 stimulation
did not alter the minimal amount of IL-1β secretion seen in
CGD donors (Figures 5F–H). Our data suggest NADPH oxidasederived ROS contributes to the enhancement of HIF-1α and
IL-1β expression observed with the loss of TSLPR signaling.

Dectin-1-Induced TSLP Negatively
Regulates Syk Activation
Dectin-1-mediated effector responses are controlled by the
recruitment and activation of Syk (28), and we have previously
shown that inhibition of Syk signaling in mDC stimulated
with dectin-1 agonists substantially reduces TSLP and IL-1β
expression (8). Furthermore, inhibition of Syk activity in DCs
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FIGURE 3 | Dectin-1-induced TSLP negatively regulates pro-IL-1β and HIF-1α. (A) Human mDC were stimulated with SC glucan, CA glucan or heat killed C. albicans
hyphae with anti-TSLPR antibodies or IgG isotype control for 24 h (n = 6 independent donors, presented as pooled data). Lactate production was measured in
cell-culture supernatants using colourmetric L-lactate detection kit. (B) Human mDC were stimulated SC glucan with either anti-TSLP, anti-TSLPR or IgG isotype
control antibodies for 8 h (n = 1 representative donor presented, three separate experiments performed). Pro-IL-1β, IL-1β, HIF-1α, phospho-p38 MAPK, p38 MAPK,
phospho-AMPK, AMPK and β-actin were measured by immunoblot. (C–G) Densitometry of cumulative data was performed using Image Studio Lite software with
pro-IL-1β, IL-1β and HIF-1α normalized to β-actin and phospho-p38 MAPK and phospho-AMPK normalized to total p38 MAPK and AMPK respectively. Data is
reported as percentage of maximal signal observed within each donor (n = 3 independent donors, presented as pooled data). Cumulative data displayed as mean
+SEM. Statistical analysis calculated using one-way ANOVA with Bonferroni post-tests (***p = 0.001).

HIF-1α and lactate production were further augmented when
TSLPR signaling was neutralized on dectin-1-stimulated mDC.
Given that Tannahill et al identified that HIF-1α expression was
crucial for pro-IL-1β induction in LPS-treated macrophages (40)
and β-glucan stimulated monocytes induce HIF-1α expression
required for this glycolytic switch (41): these data are compatible
with the idea that autocrine TSLPR signaling controls pro-IL-1β
expression in mDC by regulating HIF-1α. Further work will be
required to confirm that HIF-1α is a key factor that promotes
increased IL-1β expression when TSLPR signaling is inhibited.
IL-1β has been shown to directly induce HIF-1α expression
(47–49), but despite an increase in IL-1β when inhibiting TSLPR

Frontiers in Immunology | www.frontiersin.org

signaling, our data provide evidence that the enhanced HIF-1α
expression induced by dectin-1 occurred independently of this
cytokine. In contrast to the regulation of HIF-1α, modulation
of AMPK phosphorylation was shown to be dependent on
the secretion of IL-1β and to our knowledge this is the first
report that suggests that IL-1β may negatively regulate AMPK
activation. Our data also highlighted the differences in the
signaling requirements for ROS in AMPK activation and HIF1α expression. We showed that following dectin-1 stimulation,
phosphorylation of the AMPK catalytic subunit was unaffected
by the absence of ROS but in contrast, HIF-1α expression was
completely dependent on ROS production. Given that AMPK
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FIGURE 4 | Increased HIF-1α expression is regulated by TSLPR inhibition and not IL-1β secretion (A) Human mDC were stimulated with SC glucan with either
anti-TSLPR or IgG isotype control antibodies for 8 h in the presence or absence of IL-1β neutralization antibodies (n = 1 representative donor presented, three
separate experiments performed). Pro-IL-1β, IL-1β, HIF-1α, phospho-p38 MAPK, p38 MAPK, phospho-AMPK, AMPK and β-actin were measured by immunoblot.
(B,C) Densitometry of cumulative data was performed using Image Studio Lite software with HIF-1α normalized to β-actin and phospho-AMPK normalized to AMPK.
Data is reported as percentage of maximal signal observed within each donor (n = 3 independent donors, presented as pooled data). Cumulative data displayed as
mean +SEM.

production may directly regulate HIF-1α and pro-IL-1β, via
Syk-mediated activation of NADPH oxidase-derived ROS: a
regulatory mechanism that does not exist in CGD patients.
Therefore, dysregulation of TSLP production or TSLPR
signaling might be a feature of diseases associated with
Syk and IL-1β overproduction. Opportunistic invasive fungal
infections present serious clinical complications particularly in
immunosuppressed individuals. Given the importance of IL-1β
to anti-fungal immunity these findings describe an important
regulatory mechanism of IL-1β that could ultimately lead to the
development of approaches to boost resistance.

activation has been shown to antagonize HIF-1α expression, it
may not be surprising that the signaling requirements for these
factors have shared and distinct arms, highlighting the potential
for independent regulation of these factors in the dectin-1
signaling pathway. Most importantly, the modulation of HIF1α and AMPK in the presence of TSLPR neutralizing antibodies,
could be interpreted as complimentary responses, since enhanced
HIF-1α or a reduction in AMPK activation have been shown to
contribute to a metabolic shift toward aerobic glycolysis and the
increased production of inflammatory cytokines in monocytes
and DC (41, 50).
Our data also showed that inhibition of TSLPR signaling on
mDC enhanced Syk activation. We show that CGD patients
cannot generate ROS, HIF-1α or IL-1β secretion; and unlike
in healthy donors, mDC-derived from CGD patients do not
augment HIF-1α expression or IL-1β secretion when autocrine
TSLPR signaling is neutralized. These data are in agreement
with published work showing that both Syk and ROS regulate
IL-1β cleavage during dectin-1 stimulation (27) and that ROS
can activate HIF-1α expression (51). Therefore, autocrine TSLP

Frontiers in Immunology | www.frontiersin.org

MATERIALS AND METHODS
Ethics Statement
Human blood was sourced from apheresis cones derived from
healthy donors (HD) (Addenbrooke’s Hospital, Cambridge) and
age- and sex-matched CGD patients (Royal Free Hospital,
London). Appropriate consent to use blood-derived cells for
research was obtained. These studies were approved by the

7

May 2019 | Volume 10 | Article 921

Elder et al.

TSLP Negatively Regulates Dectin-1 Signaling

FIGURE 5 | Dectin-1-induced NADPH oxidase-derived ROS is required for augmented IL-1β during TSLPR inhibition. (A) Human mDC derived from healthy donors
(HD) or CGD patients were stimulated with SC glucan for 8 h (n = 2 representative donors presented, three separate experiments performed). Pro-IL-1β, IL-1β,
HIF-1α, phospho-AMPK, AMPK and β-actin were measured by immunoblot. (B–E) Densitometry of cumulative data was performed using Image Studio Lite software
with pro-IL-1β, IL-1β and HIF-1α normalized to β-actin and phospho-AMPK normalized to total AMPK. Data is reported as percentage of maximal signal observed
within each donor (n = 3 independent donors, presented as pooled data). (F–H) Human mDC derived from HD or CGD patients were stimulated with SC glucan, CA
glucan or heat killed C. albicans hyphae with anti-TSLPR or IgG isotype control antibodies for 24 h (n = 3 independent donors, presented as pooled data). IL-1β was
measured in 24-h cell culture supernatants by ELISA. Cumulative data displayed as mean +SEM. Statistical analysis calculated using one-way ANOVA with Bonferroni
post-tests (***p = 0.001,*p = 0.05).
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FIGURE 6 | Dectin-1-induced TSLP negatively regulates Syk activation. (A–D) Human mDC were stimulated with SC glucan with anti-TSLPR or IgG isotype control
antibodies for 2 h (n = 1 representative donor presented, three separate experiments performed). (B,C) Densitometry of cumulative data was performed using Image
Studio Lite software with phospho-Syk normalized to total Syk. Data is reported as percentage of maximal signal observed within each donor (n = 3 independent
donors, presented as pooled data). Phospho-Syk measured by (A) immunoblot and (D) confocal microscopy (Red represents p-Syk and Blue represents nuclear
DAPI staining).

Joint UCL/UCLH Committee for the Ethics of Human Research,
project number 04/Q0501/119.

for 8 h at 37◦ C to an optical density of 0.2. C. albicans was killed
◦
by heating for 1 h at 70 C.

Cell Isolation and Generation of
Dendritic Cells

Reagents
10 µg/ml sheep anti-TSLP blocking antibody (R&D Systems),
10 µg/ml sheep IgG isotype control (R&D Systems), 10 µg/ml
goat anti-TSLPR blocking antibody (R&D Systems), 10 µg/ml
goat IgG isotype control (R&D Systems), 2 µg/ml IL-1β
blocking antibody (R&D Systems), 10 µg/ml mouse IgG2B
dectin-1 blocking antibody (clone-259931 R&D Systems),
10ug/ml mouse IgG2B isotype control (clone-20116 R&D
Systems), 1 µM Syk inhibitor, R406 (Selleckchem), 1 µg/ml IL-1
receptor antagonist (IL-1RA) (R&D Systems), 50 µM caspase1 inhibitor (Z-YVAD-FMK) (Calbiochem), 50 µM caspase8 inhibitor (Z-IE(OMe)TD(OMe)-FMK) (Calbiochem). Where
inhibitors, blocking antibodies and modifiers were used, mDCs
were pre-treated 1 h prior to cell stimulation. Repeated
experiments were performed on independent donors unless
otherwise stated.

Human monocyte-derived dendritic cells (mDC) were generated
from CD14+ monocytes isolated from human PBMC by
magnetic bead separation (Miltenyi) and were differentiated by
culturing for 6-days in RPMI1640 (Lonza) 5% FCS (Biosera)
supplemented with 20 ng/ml GM-CSF (Life Technologies) and
4 ng/ml IL-4 (BD Biosciences) as described previously (8). CGD
donors were recruited at the Royal Free Hospital, London and age
and sex matched to healthy donors recruited at the University
of Cambridge, in accordance with ethical rules set out by each
institution. Human CD1c+ DC were isolated from PBMC by
magnetic bead separation (Miltenyi). Murine bone marrowderived dendritic cells (BMDC) were generated by culturing cells
isolated from bone marrow of wildtype (TSLPR+/+ ) and TSLPR
knockout (TSLPR−/− ) BALB/c mice for 7-days in RPMI1640
10% FCS supplemented with 5% X63 conditioned media and
10 ng/ml IL-4 (Peprotech).

Cytokine Production
IL-1β, IL-6, IL-23 (eBioscience), TSLP, and CCL22 (R&D)
were measured in 24 h mDC, CD1c+ DC or BMDC culture
supernatants by ELISA according to manufacturer’s protocols.

Cell Stimulations
mDCs were stimulated with 50 µg/ml of either β-1,3 glucan
(SC glucan) derived from Saccharomyces cerevisiae (S. cerevisiae)
isolated by David. L. Williams, East Tennessee State University
as previously described (52), β-1,3 glucan (CA glucan) derived
from hyphal Candida albicans (C. albicans) isolated by David.
L. Williams as previously described (53) or heat-killed hyphal
C. albicans (MOI 2:1) gifted from John Trowsdale, University of
Cambridge. C. albicans was grown in sabouraud dextrose broth

Frontiers in Immunology | www.frontiersin.org

Quantitative Real-Time PCR
mDC were stimulated for indicated time period and IL-1β,
HIF-1α, IL-6, IL-23p19 and IL-23p40 mRNA expression was
measured by quantitative real-time PCR from isolated RNA
(Norgen) using TaqMan Gene Expression Assays (Applied
Biosystems). Gene expression was normalized to HPRT and
calculated as relative expression (2-dCT).
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Immunoblot

Data Analysis

mDC were stimulated for indicated time period and protein
lystates were generated, quantified by Bradford assay (Thermo)
and resolved using SDS-PAGE. IL-1β (R&D, AB-201-AB),
HIF-1α (Novus, NB100-449), phospho-AMPK (Thr 172) (Cell
Signaling, 2535), AMPK (Cell Signaling, 5831), phosphoSyk (Tyr 525/526) (Cell Signaling, 2710), phospho-Syk (Tyr
352) (Cell Signaling, 2701), Syk (Cell Signaling, 13198),
phospho-p38 MAPK (Thr 180/ Tyr 182) (Cell Signaling,
4511), p38 MAPK (Cell Signaling, 8690) and β-actin (Abcam,
8226) protein expression were measured by immunoblot,
by incubation with indicated primary antibodies followed
by incubation with HRP-conjugated secondary antibodies,
ECL detection (PerkinElmer) and visualized using GBox
(Syngene). Densitometry of cumulative data was performed
using Image Studio Lite software. Pro-IL-1β, IL-1β and HIF1α expression was normalized to β-actin and phospho-p38
MAPK, phospho-AMPK and phospho-Syk was normalized to
total p38 MAPK, AMPK and Syk respectively. Cumulative data
is reported as percentage of maximal signal observed within
each donor.

Data were analyzed using GraphPad Prism statistical package.
Cumulative data are displayed as mean ±SEM. Statistical analysis
using either t test (p-values stated in figures legends) or oneway ANOVAs with Bonferroni post-tests ns = not significant,
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
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